264 related articles for article (PubMed ID: 6325537)
1. Dual parameter flow cytometric analysis of DNA content, activation antigen expression, and T cell subset proliferation in the human mixed lymphocyte reaction.
Williams JM; Loertscher R; Cotner T; Reddish M; Shapiro HM; Carpenter CB; Strominger JL; Strom TB
J Immunol; 1984 May; 132(5):2330-7. PubMed ID: 6325537
[TBL] [Abstract][Full Text] [Related]
2. Dual-parameter flow cytometric analysis of an early lymphocyte activation antigen (CK226) and DNA content.
Zocchi MR; Heltai S; Poggi A
Cytometry; 1989 Nov; 10(6):762-71. PubMed ID: 2582967
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte activation antigens. I. A monoclonal antibody, anti-Act I, defines a new late lymphocyte activation antigen.
Lazarovits AI; Moscicki RA; Kurnick JT; Camerini D; Bhan AK; Baird LG; Erikson M; Colvin RB
J Immunol; 1984 Oct; 133(4):1857-62. PubMed ID: 6088627
[TBL] [Abstract][Full Text] [Related]
4. Tac antigen-positive T cells activated in autologous mixed lymphocyte reaction regulate the generation of killer T cells against hapten-modified autologous cells.
Kumagai S; Namiuchi S; Ozaki S; Sano H; Tsubata T; Suginoshita T; Imura H
J Immunol; 1985 Feb; 134(2):711-7. PubMed ID: 2981269
[TBL] [Abstract][Full Text] [Related]
5. Effects of anti-interleukin-2 receptor antibody and cyclosporin A on human T cell proliferation in primary mixed lymphocyte reaction.
Oiwa K; Sakagami K; Orita K
Hiroshima J Med Sci; 1989 Mar; 38(1):1-6. PubMed ID: 2526799
[TBL] [Abstract][Full Text] [Related]
6. Proliferating cell nuclear antigen (PCNA)/cyclin in activated human T lymphocytes.
Kurki P; Lotz M; Ogata K; Tan EM
J Immunol; 1987 Jun; 138(12):4114-20. PubMed ID: 2884260
[TBL] [Abstract][Full Text] [Related]
7. Generation of natural killer-like activity in mixed lymphocyte-tumor cell cultures. II. Correlation between expression of HLA-DR antigens on the activated T cells and their cytotoxic capability.
Santoli D; Francis MK; Matera L
Nat Immun Cell Growth Regul; 1985; 4(2):103-12. PubMed ID: 3160933
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies that inhibit activation and proliferation of lymphocytes. II. Requisite role of the monoclonal antibody-defined antigen systems in activation and proliferation of human and rat lymphocytes.
Yagita H; Hashimoto Y
J Immunol; 1986 Mar; 136(6):2062-8. PubMed ID: 2419421
[TBL] [Abstract][Full Text] [Related]
9. The monoclonal antibodies Trop-4 and 4F2 detect the same membrane antigen that is expressed at an early stage of lymphocyte activation and is retained on secondary lymphocytes.
Suomalainen HA
J Immunol; 1986 Jul; 137(2):422-7. PubMed ID: 3487571
[TBL] [Abstract][Full Text] [Related]
10. Accessory cell requirement for activation antigen expression and cell cycle progression by human T lymphocytes.
Williams JM; Ransil BJ; Shapiro HM; Strom TB
J Immunol; 1984 Dec; 133(6):2986-95. PubMed ID: 6092462
[TBL] [Abstract][Full Text] [Related]
11. Association of protein kinase C activation with IL 2 receptor expression.
Farrar WL; Ruscetti FW
J Immunol; 1986 Feb; 136(4):1266-73. PubMed ID: 3003192
[TBL] [Abstract][Full Text] [Related]
12. Reduced alloreactive T-cell activation after alcohol intake is due to impaired monocyte accessory cell function and correlates with elevated IL-10, IL-13, and decreased IFNgamma levels.
Szabo G; Mandrekar P; Dolganiuc A; Catalano D; Kodys K
Alcohol Clin Exp Res; 2001 Dec; 25(12):1766-72. PubMed ID: 11781510
[TBL] [Abstract][Full Text] [Related]
13. Sequential expression of T cell activation (Tac) antigen and Ia determinants on circulating human T cells after immunization with tetanus toxoid.
Yachie A; Miyawaki T; Uwadana N; Ohzeki S; Taniguchi N
J Immunol; 1983 Aug; 131(2):731-5. PubMed ID: 6306105
[TBL] [Abstract][Full Text] [Related]
14. Desferoxamine blocks IL 2 receptor expression on human T lymphocytes.
Carotenuto P; Pontesilli O; Cambier JC; Hayward AR
J Immunol; 1986 Apr; 136(7):2342-7. PubMed ID: 3005409
[TBL] [Abstract][Full Text] [Related]
15. Two-color flow cytometry and functional analysis of lymphocytes cultured from human renal allografts: identification of a Leu-2+3+ subpopulation.
Preffer FI; Colvin RB; Leary CP; Boyle LA; Tuazon TV; Lazarovits AI; Cosimi AB; Kurnick JT
J Immunol; 1986 Nov; 137(9):2823-30. PubMed ID: 3093583
[TBL] [Abstract][Full Text] [Related]
16. S152 (CD27). A modulating disulfide-linked T cell activation antigen.
Bigler RD; Bushkin Y; Chiorazzi N
J Immunol; 1988 Jul; 141(1):21-8. PubMed ID: 2837508
[TBL] [Abstract][Full Text] [Related]
17. Alloantigen-induced human lymphocytes rendered nonresponsive by a combination of anti-CD80 monoclonal antibodies and cyclosporin-A suppress mixed lymphocyte reaction in vitro.
Comoli P; Montagna D; Moretta A; Zecca M; Locatelli F; Maccario R
J Immunol; 1995 Dec; 155(12):5506-11. PubMed ID: 7499831
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of cell activation markers after stimulation of resting human B lymphocytes.
Kehrl JH; Muraguchi A; Fauci AS
J Immunol; 1984 Jun; 132(6):2857-61. PubMed ID: 6427329
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous increased expression of E-rosette receptor (CD2, T11) and T cell growth factor receptor on human T lymphocytes during activation.
Redelman D
Cytometry; 1987 Mar; 8(2):170-83. PubMed ID: 3107949
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibodies that inhibit activation and proliferation of lymphocytes. I. Expression of the antigen on monocytes and activated lymphocytes.
Yagita H; Masuko T; Takahashi N; Hashimoto Y
J Immunol; 1986 Mar; 136(6):2055-61. PubMed ID: 3950410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
